Galapagos

📍 Mechelen, Belgium🗓 Founded 1999👥 1,369 employees💰 Last funded 2013
Biotechnology Research🌐 glpg.com
Website LinkedIn
We are a fully integrated biotechnology company focused on discovering, developing, and commercializing innovative medicines. We are committed to improving patients’ lives worldwide by targeting diseases with high unmet needs. Our R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Our portfolio comprises discovery through to Phase 4 programs in immunology, oncology, and other indications. Our first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1999
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Galapagos?
Galapagos has 1 investors on record on gritt.io.
When did Galapagos last raise funding?
The most recent investment in Galapagos recorded on gritt.io was in 2013.
When was Galapagos founded?
Galapagos was founded in 1999.
What industry is Galapagos in?
Galapagos operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Galapagos based?
Galapagos is headquartered in Mechelen, Belgium.